PharmaBoardroom

Regulatory Reform: Russia

Upcoming reforms in Russia's pharma environment. Prepared in association with Lidings, a leading global law firm, this is an extract from The Pharma…

Patents and Trademarks: Russia

All about patents and trademarks in Russia. Prepared in association with Lidings, a leading global law firm, this is an extract from The Pharma…

Product Liability: Russia

The lowdown on the situation regarding the product liability in Russian Pharma. Prepared in association with Lidings, a leading global law firm, this…

Traditional Medicines and OTC Products: Russia

A brief overview of the situation regarding traditional medicines and OTC products in Russia. Prepared in association with Lidings, a leading global…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…

Learn more about marketing, manufacturing, packaging & labeling, and advertising in Russian pharma. Prepared in association with Lidings, a…

Preclinical and Clinical Trial Requirements: Russia

All about preclinical and clinical trial requirements in Russia. Prepared in association with Lidings, a leading global law firm, this is an extract…

Regulatory, Pricing and Reimbursement Overview: Russia

An intro to the legal situation for regulatory, pricing and reimbursement in Russia. Prepared in association with Lidings, a leading global law firm,…

Beh Kian Teik – Deputy CEO, National Research Foundation…

Beh Kian Teik of Singapore’s National Research Foundation (NRF) outlines the importance of the life sciences within the country’s innovation…

Abhay Bangi – Partner, Life Sciences & Healthcare Lead…

EY’s Abhay Bangi highlights the key trends across the ASEAN life sciences space, how the COVID-19 pandemic has accelerated them, and charts…

Aileen Lai – CEO & Founder, HealthBeats

Innovation is at the heart of healthcare transformation and the doors for a much-needed shift from provider- to patient-centric solutions have been…

Novartis Mexico Gets “Aggressive”; Country President Foresees…

During a year where the Mexican economy shrank 8.5 percent, Novartis Mexico experienced a modest one percent growth which Country President Fernando…

Colombia Pharma News: $25 million US Cannabis Deal; COVID-Related…

The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced…

Tagged with M